These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4113144)

  • 1. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ; Rapp E
    Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical lomustine in the treatment of psoriasis.
    Peck GL; Guss SB; Key DJ
    Arch Dermatol; 1972 Aug; 106(2):172-6. PubMed ID: 4558698
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Reitemeier RJ; Schutt AJ; Hahn RG
    Cancer Chemother Rep; 1971 Jun; 55(3):303-7. PubMed ID: 5115851
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC; DeVita VT; Serpick AA; Canellos GP
    N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF; Catalano RB; Creech RH
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of mycosis fungoides with topical nitrosourea compounds.
    Zackheim HS
    Arch Dermatol; 1972 Aug; 106(2):177-82. PubMed ID: 5048217
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma.
    Moertel CG; Douglass HO; Hanley J; Carbone PP
    Cancer Treat Rep; 1976 Nov; 60(11):1659-61. PubMed ID: 1035508
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
    Gailani S; Kutcher J
    J Med; 1973; 4(4):209-18. PubMed ID: 4520348
    [No Abstract]   [Full Text] [Related]  

  • 11. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
    Giles GR; Hall R; Brennan TG; Worthy TS
    Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 13. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD; Hurwitz BS
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract]   [Full Text] [Related]  

  • 14. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB; Boldrey EB; Enot KJ
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract]   [Full Text] [Related]  

  • 16. The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Drewinko B; Novak JK; Barranco SC
    Cancer Res; 1972 Jun; 32(6):1206-8. PubMed ID: 4113143
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
    Bray DA; DeVita VT; Adamson RH; Oliverio VT
    Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW; Humphrey EW
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract]   [Full Text] [Related]  

  • 20. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB; Falkson HC; Falkson G
    Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.